Physician
Neurocare Center INC
Neurocare Center INC was paid $2.74M by Medicaid between Jan 2018 and Dec 2024, across 37 billing codes. Its largest line is 99214, doctor's office visit, returning patient (more involved) — 61% of everything it billed.
33Billing provider infoNEUROCARE CENTER INC
CANTON, OH 44718
CANTON, OH 44718
33aNPI1689769572assigned 10/04/2006
33bProvider typeNeurology Physician
28Total paid$2.74M
24GClaims61,840
24DCodes billed37
24AFirst – last monthJan 2018 – Dec 2024
Compared with peers
Next to other Neurology Physician providers in Ohio
Rank by total paid#4 of 61
Median peer was paid$39K
This provider vs. median69×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 10,287 | $477K | |
| 2019 | 8,326 | $405K | |
| 2020 | 7,201 | $338K | |
| 2021 | 8,011 | $383K | |
| 2022 | 8,593 | $419K | |
| 2023 | 7,904 | $372K | |
| 2024incomplete | 11,518 | $344K |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 99214 | Doctor's office visit, returning patient (more involved)Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity | 61% | 35,791 | 33,611 | $1.68M |
| 99213 | Doctor's office visit, returning patient (routine)Office or other outpatient visit for the evaluation and management of an established patient, low complexity | 8.4% | 7,410 | 7,085 | $231K |
| 99215 | Doctor's office visit, returning patient (complex)Prolong outpt/office vis | 6.8% | 3,251 | 3,045 | $186K |
| 99204 | Doctor's office visit, new patient (more involved)Office or other outpatient visit for the evaluation and management of a new patient, moderate complexity | 6.3% | 2,618 | 2,457 | $173K |
| 95886 | 3.6% | 2,384 | 2,262 | $100K | |
| 64615 | 2.4% | 810 | 759 | $66K | |
| 99205 | Prolong outpt/office vis | 2.2% | 715 | 683 | $59K |
| 95911 | 1.8% | 499 | 467 | $50K | |
| 95816 | 1.7% | 974 | 915 | $47K | |
| 95810 | Polysomnography; sleep staging with 4 or more additional parameters | <1% | 117 | 111 | $25K |
| 99245 | <1% | 260 | 249 | $24K | |
| 95819 | <1% | 286 | 275 | $15K |
25 more codes
| 99223 | Prolong inpt eval add15 m | <1% | 272 | $13K |
| 96375 | Therapeutic injection; each additional sequential IV push | <1% | 115 | $9K |
| 95811 | <1% | 39 | $9K | |
| J0586 | Injection, abobotulinumtoxina, 5 units | <1% | 22 | $8K |
| 96365 | Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour | <1% | 169 | $8K |
| J1110 | Injection, dihydroergotamine mesylate, per 1 mg | <1% | 81 | $7K |
| 70553 | Magnetic resonance imaging, brain; without contrast material, followed by contrast material and further sequences | <1% | 26 | $6K |
| 99244 | Office or other outpatient consultation, moderate to high complexity | <1% | 76 | $5K |
| 95909 | <1% | 73 | $5K | |
| 96366 | Intravenous infusion, for therapy, prophylaxis, or diagnosis; each additional hour | <1% | 115 | $4K |
| 99232 | Hospital visit by a doctor, follow-up day | <1% | 68 | $977.97 |
| 95991 | <1% | 18 | $688.49 | |
| 93005 | Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report | <1% | 114 | $681.57 |
| 99236 | Prolong inpt eval add15 m | <1% | 12 | $604.57 |
| A9575 | Injection, gadoterate meglumine, 0.1 ml | <1% | 13 | $447.05 |
| 99233 | Hospital visit by a doctor, follow-up day (complex) | <1% | 18 | $239.68 |
| J1885 | Injection, ketorolac tromethamine, per 15 mg | <1% | 107 | $237.41 |
| J7030 | Infusion, normal saline solution , 1000 cc | <1% | 113 | $184.40 |
| A9577 | Injection, gadobenate dimeglumine (multihance), per ml | <1% | 16 | $173.80 |
| 95874 | <1% | 15 | $128.76 | |
| G2211 | Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's single, serious condition or a complex condition. (add-on code, list separately in addition to office/outpatient evaluation and management visit, new or established) | <1% | 4,884 | $79.46 |
| J2405 | Injection, ondansetron hydrochloride, per 1 mg | <1% | 110 | $71.84 |
| J2060 | Injection, lorazepam, 2 mg | <1% | 88 | $58.63 |
| J1100 | Injection, dexamethasone sodium phosphate, 1 mg | <1% | 80 | $38.99 |
| 94761 | <1% | 81 | $11.30 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialCASANOVA, JOSE (AUTHORIZED OFFICIAL)